AI Science Tracker
EN

Artificial intelligence accelerates the identification of nature-derived potent LOXL2 inhibitors.

Affiliation not stated in the reviewed material · 27 Mar 2025 · medicine

Discovery

Artificial intelligence accelerates the identification of nature-derived potent LOXL2 inhibitors.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: Graph-convolutional DeepVS screened natural-product libraries and prioritized Forsythoside A; CT26 cell assays measured proliferation, migration, apoptosis and LOXL2 expression.

Technology: Graph-convolutional DeepVS screened natural-product libraries and prioritized Forsythoside A; CT26 cell assays measured proliferation, migration, apoptosis and LOXL2 expression.

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
Graph-convolutional DeepVS screened natural-product libraries and prioritized Forsythoside A; CT26 cell assays measured proliferation, migration, apoptosis and LOXL2 expression.
Limitation / still unknown
Cell-assay findings in CT26 models do not establish in-vivo antitumor efficacy, safety or human therapeutic benefit.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11950171/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.